Zika vaccine advances to phase 2 testing
- Posted on: Dec 8 2017
A new Zika vaccine shows promising safety and immunogenicity, according to a phase 1 trial by the Vaccine Research Center at the NIH.
Source: AAO
Posted in: Practice News
A new Zika vaccine shows promising safety and immunogenicity, according to a phase 1 trial by the Vaccine Research Center at the NIH.
Source: AAO
Posted in: Practice News
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »